Keyphrases
Doxorubicin
100%
Aged Mice
100%
Tumor Inflammation
100%
Tumor-free
62%
Tumor-bearing Mice
50%
Inflammatory Response
37%
Doxorubicin Treatments
37%
Tumor
25%
Liver
25%
EL4 Lymphoma
25%
Gene Expression
12%
Inflammation
12%
Pediatric Oncology
12%
Tumor Growth
12%
Mouse Model
12%
Quantitative PCR
12%
C57BL
12%
Kidney
12%
Therapeutic Agents
12%
Serum Concentration
12%
Adverse Effects
12%
Inflammatory Markers
12%
Heart-kidney
12%
Lymphoma Cells
12%
Young Males
12%
Divergent Effects
12%
Multiple Organs
12%
Pathologic Conditions
12%
Tumor Implantation
12%
Cardiac Atrophy
12%
Euthanized
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Inflammation
100%
Neoplasm
100%
Mouse Model
7%
Enzyme-Linked Immunosorbent Assay
7%
C57BL/6N Mouse
7%
Malignant Neoplasm
7%
Antiinfective Agent
7%
Tumor Growth
7%
Adverse Event
7%
Childhood Cancer
7%
Medicine and Dentistry
Neoplasm
100%
Doxorubicin
100%
Serositis
23%
Malignant Neoplasm
7%
Chemotherapeutic Agent
7%
Childhood Cancer
7%
Tumor Progression
7%
Antiinfective Agent
7%
Gene Expression
7%
Adverse Event
7%
Lymphoma Cell
7%
Enzyme Linked Immunosorbent Assay
7%
Real Time Polymerase Chain Reaction
7%
Flank
7%
Cancer Transplantation
7%